Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%
Earnings

Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance

By The Northwire Desk — AI Analysis Nov 26, 2025 · 18:25 NURS · 5.28 Hydreight Technologies Inc.
NURS · Price

Executive Summary

  • Hydreight Technologies reported Q3 2025 revenue of C$12.83 M (top‑line) and GAAP revenue of C$10.52 M, representing 110% and 132% year‑over‑year growth respectively.
  • The company posted its first GAAP net profit in a quarter since inception – C$361,888 – after a loss of C$89,938 in Q3 2024; Adjusted EBITDA rose to C$620 K (+1,200%).
  • Cash on hand increased to C$18.64 M and the firm announced a strategic equity investment (5% stake with an option up to 40%) in Perfect Scripts, LLC, plus ongoing M&A pipeline activity.

Key Details

  • Revenue Growth:
  • Q3 2025 top‑line revenue: C$12,833,898 (+110% YoY).
  • First nine months 2025 revenue: C$26,710,651 (+61% YoY).

  • GAAP revenue Q3 2025: C$10,519,538 (+132% YoY).

  • Profitability:

  • GAAP Net Income Q3 2025: C$361,888 (vs. a loss of C$89,938 in Q3 2024).
  • Adjusted EBITDA Q3 2025: C$619,752 (+1,200% YoY).

  • Gross Margin Q3 2025: C$2,330,320 (up from C$1,533,171 YoY).

  • Cash Position:

  • Cash on hand at quarter‑end: C$18.64 M.

  • Operational Metrics:

  • ~295,000 VSDHOne product orders processed July–Sept 2025 across multiple wellness verticals.
  • Nurse network grew 49% YoY (198 new sign‑ups Q3 vs. 133 in Q3 2024); 593 new nurses YTD vs. 364 prior year (+63%).

  • Pharmacy order volume up ~72% YoY.

  • Strategic Transactions:

  • Signed definitive agreement to acquire a 5% equity stake in Perfect Scripts, LLC with an option to increase to 40%; partnership includes joint development of pharmacy‑fulfillment capabilities.

  • Ongoing evaluation of additional multi‑state wellness and digital‑health operators for acquisition.

  • Product & Technology Updates:

  • Integration of additional 503A/503B pharmacy partners to boost capacity and margin.

  • Upcoming release of VSDHOne V2 – enhanced automation, scalability, and modular functionality.

  • Awards & Recognition:

  • Ranked #77 on Deloitte Technology Fast 500 (North America) 2025; #25 on Deloitte Technology Fast 50 (Canada).

  • Upcoming Investor Call:

  • Date: Friday, 28 Nov 2025, 11:00‑12:00 am PST. Registration link provided in release.

Notable Quotes

“We are very pleased with the momentum behind VSDHOne… the platform only began operating in a meaningful way toward the end of June, and since then it has contributed to both revenue growth and sustained profitability.” – Shane Madden, CEO

All non‑material boilerplate, forward‑looking disclaimer language, and generic “About” sections have been omitted.

Read the original news release →

More from Hydreight Technologies Inc.

Jun 01, 2026 · 21:32

Hydreight's Q1 EBITDA Margin Expansion Validates Operating Leverage, But Valuation Premium Demands Flawless Execution

Earnings May 01, 2026 · 00:14

Victory Square Technologies Inc.

Earnings Apr 30, 2026 · 20:56

Hydreight Validates Profitability Model But Aggressive 2026 Guidance Looms

Earnings Mar 13, 2026 · 18:43

Hydreight closes acquisition of 800,000 Insu units

M&A / Property Mar 13, 2026 · 16:15

Hydreight Technologies Closes Strategic Investment in Insu Therapeutics

Financings Mar 09, 2026 · 08:00

Hydreight Announces Normal Course Issuer Bid

Other